17β-(Cyclopropylamino)-androst-5-en-3β-ol, a selective mechanism-based inhibitor of cytochrome P45017α (steroid 17α-hydroxylase/C17–20 lyase)
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 162 (3) , 1571-1577
- https://doi.org/10.1016/0006-291x(89)90854-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of ketoconazole on placental aromatase, 3β-hydroxysteroid dehydrogenase-isomerase and 17β-hydroxysteroid dehydrogenaseThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Ketoconazole and Other Imidazole Derivatives as Inhibitors of SteroidogenesisEndocrine Reviews, 1986
- Cytochromes P-450 and the regulation of steroid synthesisSteroids, 1986
- Discriminatory inhibition of adrenocortical 17α-hydroxylase activity by inhibitors of cholesterol side chain cleavage cytochrome P-450Archives of Biochemistry and Biophysics, 1985
- KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCERThe Lancet, 1984
- Site of Action of Low Dose Ketoconazole on Androgen Biosynthesis in Men*Journal of Clinical Endocrinology & Metabolism, 1983
- Clinical and Biochemical Effect of Aminoglutethimide in the Treatment of Advanced Prostatic CarcinomaJournal of Urology, 1983
- Inhibitor of human adrenal C17–20 lyase and C19-5-ene, 3β-hydroxysteroid dehydrogenasJournal of Steroid Biochemistry, 1975
- Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applicationsThe Journal of Steroid Biochemistry and Molecular Biology, 1974
- Steroidal androgen biosynthesis inhibitorsJournal of Medicinal Chemistry, 1971